Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck ...Middle East

PR Newswire - News
HELSINGBORG, Sweden, Feb. 16, 2023 /PRNewswire/ -- AQILION AB ("Aqilion") today announced an exclusive license and strategic research collaboration with Merck to discover, develop and commercialize small molecule inhibitors of the transforming growth factor-β-activated kinase 1 (TAK1)...

Hence then, the article about aqilion announces pre clinical licensing and strategic research collaboration agreement with merck was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News